See more : thyssenkrupp AG (TKAMY) Income Statement Analysis – Financial Results
Complete financial analysis of PainChek Limited (PCK.AX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of PainChek Limited, a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- eDreams ODIGEO S.A. (EDDRF) Income Statement Analysis – Financial Results
- Xinyi Solar Holdings Limited (XISHY) Income Statement Analysis – Financial Results
- Oishi Group PLC (OSHIF) Income Statement Analysis – Financial Results
- Delta Plus Group (ALDLT.PA) Income Statement Analysis – Financial Results
- Renalytix Plc (RENX.L) Income Statement Analysis – Financial Results
PainChek Limited (PCK.AX)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.painchek.com
About PainChek Limited
PainChek Limited develops and commercializes mobile medical device applications that provides pain assessment for individuals. The company offers PainChek, which uses camera in smartphones and tablets to capture video that is analyzed in real time using facial recognition software to indicate the presence of the pain. It serves patients suffering with dementia. The company was formerly known as ePAT Technologies Ltd and changed its name to PainChek Limited in January 2018. PainChek Limited is based in Sydney, Australia.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.67M | 1.95M | 978.57K | 214.80K | 248.19K | 215.46K | 50.65K | 31.12K | 3.89K | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 1.95M | 1.24M | 1.24M | 639.01K | 265.17K | 0.00 | 1.71M | 150.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 726.66K | 712.51K | -258.83K | -424.21K | -16.98K | 215.46K | -1.66M | 30.97K | 3.89K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 27.20% | 36.55% | -26.45% | -197.49% | -6.84% | 100.00% | -3,275.34% | 99.52% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 4.57M | 3.82M | 2.35M | 2.65M | 2.27M | 1.89M | 1.70M | 821.43K | 83.51K | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 2.91M | 3.03M | 2.67M | 3.61M | 2.58M | 1.49M | 1.18M | 3.01M | 1.09M | 697.80K | 390.08K | 439.44K | 269.76K |
| Selling & Marketing | 2.05M | 1.86M | 1.66M | 1.57M | 1.26M | 729.25K | 318.91K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 5.67M | 5.66M | 4.98M | 5.89M | 12.75M | 2.33M | 1.86M | 3.01M | 1.09M | 697.80K | 390.08K | 439.44K | 269.76K |
| Other Expenses | 0.00 | 1.18M | 1.85M | 2.89M | 2.60M | 745.26K | 410.01K | -4.50M | 83.22K | 6.43K | 416.28K | 21.53K | 155.21K |
| Operating Expenses | 10.24M | 9.47M | 7.33M | 8.55M | 15.02M | 3.48M | 3.15M | 4.01M | 1.41M | 981.18K | 806.36K | 1.18M | 424.97K |
| Cost & Expenses | 12.19M | 10.71M | 8.57M | 9.18M | 15.29M | 3.48M | 4.86M | 4.01M | 1.41M | 981.18K | 806.36K | 1.18M | 424.97K |
| Interest Income | 6.75K | 6.35K | 15.58K | 19.09K | 48.98K | 80.44K | 26.23K | 31.12K | 600.00 | 549.00 | 14.09K | 60.06K | 19.33K |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 357.16K | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 25.57K | 16.98K | 14.42K | 59.53K | 43.03K | 3.17K | 4.03K | 150.00 | 30.14K | 47.19K | 26.06K | 25.57K | 703.00 |
| EBITDA | -9.49M | -8.61M | -6.80M | -8.91M | -13.15M | -4.00M | -4.81M | -3.90M | -57.38K | -927.01K | -766.21K | -1.07M | -404.94K |
| EBITDA Ratio | -355.12% | -448.57% | -774.09% | -4,147.99% | -6,042.63% | -1,512.67% | -9,490.19% | -12,871.00% | -33,234.79% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -9.51M | -8.76M | -7.59M | -8.97M | -15.04M | -3.26M | -4.81M | -4.01M | -1.41M | -981.18K | -806.36K | -1.18M | -424.97K |
| Operating Income Ratio | -356.07% | -449.45% | -775.56% | -4,175.71% | -6,059.97% | -1,514.14% | -9,498.16% | -12,871.48% | -36,162.74% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 1.21M | 138.68K | 776.19K | 1.85M | 1.85M | 828.87K | 410.01K | -4.50M | 0.00 | 6.98K | -72.90K | -234.33K | 19.33K |
| Income Before Tax | -8.31M | -8.62M | -6.81M | -7.12M | -13.19M | -3.26M | -4.81M | -8.47M | -1.68M | -974.19K | -792.27K | -1.10M | -405.64K |
| Income Before Tax Ratio | -310.93% | -442.33% | -696.25% | -3,315.66% | -5,314.99% | -1,514.14% | -9,498.16% | -27,232.94% | -43,185.92% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | -1.05M | -1.09M | -1.06M | -798.84K | -745.26K | 0.00 | -31.27K | 3.81M | 728.99K | 0.00 | -60.06K | 0.00 |
| Net Income | -8.31M | -7.57M | -5.72M | -6.06M | -12.39M | -3.26M | -4.81M | -8.47M | -5.05M | -1.70M | -792.27K | -1.10M | -405.64K |
| Net Income Ratio | -310.93% | -388.54% | -584.58% | -2,822.95% | -4,993.13% | -1,514.14% | -9,498.16% | -27,232.94% | -129,687.80% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | 0.00 | -0.01 | -0.02 | -0.04 | -0.04 | -0.04 | -0.06 | -0.04 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | 0.00 | -0.01 | -0.02 | -0.04 | -0.04 | -0.04 | -0.06 | -0.04 |
| Weighted Avg Shares Out | 1.46B | 1.29B | 1.13B | 1.12B | 992.31M | 841.07M | 800.94M | 521.00M | 135.01M | 41.23M | 18.55M | 18.08M | 9.90M |
| Weighted Avg Shares Out (Dil) | 1.46B | 1.29B | 1.13B | 1.12B | 992.31M | 841.07M | 800.94M | 521.00M | 135.01M | 41.23M | 18.55M | 18.08M | 9.90M |
Source: https://incomestatements.info
Category: Stock Reports